ES8502446A1 - Procedimiento para la obtencion de compuestos de hexapiranosa. - Google Patents

Procedimiento para la obtencion de compuestos de hexapiranosa.

Info

Publication number
ES8502446A1
ES8502446A1 ES522435A ES522435A ES8502446A1 ES 8502446 A1 ES8502446 A1 ES 8502446A1 ES 522435 A ES522435 A ES 522435A ES 522435 A ES522435 A ES 522435A ES 8502446 A1 ES8502446 A1 ES 8502446A1
Authority
ES
Spain
Prior art keywords
derivatives
pharmaceutical compositions
compositions containing
phosphorylated
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522435A
Other languages
English (en)
Other versions
ES522435A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES522435A0 publication Critical patent/ES522435A0/es
Publication of ES8502446A1 publication Critical patent/ES8502446A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE HEXAPIRANOSA, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) O CON UN DERIVADO REACTIVO DEL MISMO.DE APLICACION EN LA OBTENCION DE PREPARADOS FARMACEUTICOS POR SUS PROPIEDADES INMUNOMODULADORAS, ESPECIALMENTE INMUNOESTIMULANTES.
ES522435A 1981-01-23 1983-05-16 Procedimiento para la obtencion de compuestos de hexapiranosa. Expired ES8502446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH43981 1981-01-23

Publications (2)

Publication Number Publication Date
ES522435A0 ES522435A0 (es) 1985-01-01
ES8502446A1 true ES8502446A1 (es) 1985-01-01

Family

ID=4187055

Family Applications (3)

Application Number Title Priority Date Filing Date
ES508944A Expired ES8406502A1 (es) 1981-01-23 1982-01-21 Procedimiento para la obtencion de compuestos de hexapiranosa.
ES522435A Expired ES8502446A1 (es) 1981-01-23 1983-05-16 Procedimiento para la obtencion de compuestos de hexapiranosa.
ES528142A Expired ES8606370A1 (es) 1981-01-23 1983-12-16 Procedimiento para la obtencion de compuestos de hexapiranosa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES508944A Expired ES8406502A1 (es) 1981-01-23 1982-01-21 Procedimiento para la obtencion de compuestos de hexapiranosa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES528142A Expired ES8606370A1 (es) 1981-01-23 1983-12-16 Procedimiento para la obtencion de compuestos de hexapiranosa

Country Status (17)

Country Link
US (1) US4423038A (es)
EP (1) EP0056992A1 (es)
JP (1) JPS57142996A (es)
AU (1) AU7975182A (es)
CA (1) CA1190221A (es)
DD (1) DD202169A5 (es)
DK (1) DK28282A (es)
ES (3) ES8406502A1 (es)
FI (1) FI820178L (es)
GB (1) GB2092591B (es)
GR (1) GR78246B (es)
IE (1) IE820137L (es)
IL (1) IL64847A (es)
NO (1) NO152904C (es)
NZ (1) NZ199545A (es)
PT (1) PT74326A (es)
ZA (1) ZA82433B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
FI79330C (fi) * 1982-07-23 1989-12-11 Ciba Geigy Ag Foerfarande foer framstaellning av farmakologiskt verkande muramylpeptid-n-(2-fosfatidyloxietyl)-amider.
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
WO1985004881A1 (en) * 1984-04-21 1985-11-07 Sandoz Ag 2,3-dinamo-2,3-didesoxyhexose derivatives, processes for their preparation and their use
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US20020123476A1 (en) * 1991-03-19 2002-09-05 Emanuele R. Martin Therapeutic delivery compositions and methods of use thereof
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
KR100224539B1 (ko) * 1991-03-19 1999-10-15 잭 제이 루체스 개선된 생물학적 활성을 가진 폴리옥시프로필렌/폴리옥시에틸렌 공중합체 조성물
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
US6267968B1 (en) 1995-04-07 2001-07-31 Vacsyn S.A. MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
EP0821068A3 (en) * 1996-03-29 1999-06-02 Rohm And Haas Company Novel sphingolipids and a process thereto
AU2002302977A1 (en) * 2001-05-31 2002-12-09 Daiichi Suntory Pharma Co., Ltd. Assay method for platelet-activating factor
FR2933984B1 (fr) * 2008-07-15 2013-01-04 Univ Bourgogne D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
AU2010229835B2 (en) 2009-03-25 2015-01-15 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
FR2369292A1 (fr) * 1976-11-02 1978-05-26 Anvar Agents adjuvants immunit
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
EP0056992A1 (de) 1982-08-04
JPS57142996A (en) 1982-09-03
ES522435A0 (es) 1985-01-01
IL64847A0 (en) 1982-03-31
IL64847A (en) 1986-02-28
GR78246B (es) 1984-09-26
GB2092591B (en) 1984-07-04
ES508944A0 (es) 1984-07-01
NO820200L (no) 1982-07-26
NO152904B (no) 1985-09-02
ZA82433B (en) 1982-12-29
DD202169A5 (de) 1983-08-31
IE820137L (en) 1982-07-23
ES8406502A1 (es) 1984-07-01
GB2092591A (en) 1982-08-18
AU7975182A (en) 1982-07-29
ES8606370A1 (es) 1986-04-16
CA1190221A (en) 1985-07-09
US4423038A (en) 1983-12-27
FI820178L (fi) 1982-07-24
ES528142A0 (es) 1986-04-16
NO152904C (no) 1985-12-11
DK28282A (da) 1982-07-24
NZ199545A (en) 1985-07-12
PT74326A (en) 1982-02-01

Similar Documents

Publication Publication Date Title
ES8606370A1 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
DE3163802D1 (en) Cephalosporin derivatives, pharmaceutical compositions and process for their preparation
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
IL97025A0 (en) 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives,their preparation and pharmaceutical compositions containing them
PT79840B (en) Process for the preparation of polipeptides with alpha-amilase inhibiting action and pharmaceutical compositions therewith
DE3378580D1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them
HUT49614A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
IL85658A (en) Pharmaceutical compositions containing substituted pyridine-2,4-dicarboxylic acid derivatives,some such compounds and processes for their preparation
IL61989A0 (en) Phenyl piperazine derivatives of 1,3,4-oxadiazolylphenols,their preparation and pharmaceutical compositions containing them
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
ES8701182A1 (es) Un procedimiento para preparar sal monosodica del acido 7-d-mandelamido-3-(1-sulfometiltetrazol-5-il)tiometil-3-cefem-4-carboxilico
ES8206544A1 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas
HUT42492A (en) Process for producing cepheme-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
ES8101579A1 (es) Procedimiento para la obtencion de un derivado del aldehido 3,4-dihidroxicinamico
ES8302721A1 (es) Un procedimiento para la preparacion de derivados de cefa- losporina